Healthcare And Medical Devices Testing Inspection And Certification Market: Market Size & Forecast 2026

The Healthcare and Medical Devices TIC market provides independent verification that medical products meet stringent quality, safety, and regulatory standards before they reach the market. Services span testing of materials and performance, physical inspection of manufacturing processes, and certification against frameworks such as ISO 13485, FDA requirements, and the EU Medical Device Regulation (MDR). The sector sits within the much larger global TIC industry, which is expected to grow from $221.4 billion in 2021 to over $309.7 billion by 2030.

• •Global healthcare and medical devices TIC market: ~$7.35 billion in 2025, growing to ~$7.67 billion in 2026
• •Medical device TIC outsourcing segment: ~$3.18 billion in 2024, projected ~$5.1-5.5 billion by 2030-2032
• •Overall global TIC market: ~$221.4 billion (2021) to ~$309.7 billion (2030)

The rollout of the EU MDR and evolving FDA guidelines have made pre-market and post-market compliance more rigorous, directly increasing demand for third-party testing and certification. At the same time, medical device manufacturers, especially smaller ones, are increasingly outsourcing TIC functions rather than maintaining in-house labs, as it is more cost-effective and provides access to specialized expertise. The proliferation of connected and software-driven medical devices has also introduced new testing categories around cybersecurity, interoperability, and data integrity.

• •Stricter global regulatory frameworks (EU MDR, FDA updates) are raising the volume and complexity of required testing
• •Growing adoption of outsourcing by medical device OEMs to reduce costs and access niche testing capabilities
• •Rise of digital health, IoT-enabled devices, and software as a medical device (SaMD) creating new TIC requirements

The market is typically segmented by service type, testing services, inspection services, and certification services, as well as by sourcing model (outsourced vs. in-house) and end-use sector. North America is the dominant regional market, supported by a large and mature medical device industry, an established regulatory ecosystem, and high outsourcing rates. Asia-Pacific is the fastest-growing region, driven by expanding domestic manufacturing in countries such as China and India and increasing regulatory convergence with international standards.

• •North America leads the regional TIC market, driven by a mature healthcare industry and high outsourcing adoption
• •Asia-Pacific is the fastest-growing region, supported by medical device manufacturing expansion and regulatory harmonization
• •Key industry segments include medical devices (largest share), pharmaceuticals, and diagnostics/life sciences

What are the recent trends and outlook?

Looking ahead, the market is expected to sustain its 8.63% compound annual growth rate through 2032, supported by continued regulatory tightening, the ongoing digitalization of healthcare products, and expanding medical device manufacturing in emerging markets. Sustainability and environmental compliance are emerging as additional TIC considerations, with growing emphasis on the recyclability and chemical safety of medical products. The long-term outlook points toward deeper integration of digital testing platforms, remote inspection technologies, and AI-assisted quality processes that can further streamline compliance workflows.

• •Market projected to sustain ~8.63% CAGR through 2032, reaching significantly higher valuation than the 2025 base
• •Digital testing platforms, remote inspection technologies, and AI-assisted quality processes are gaining adoption
• •Environmental and sustainability compliance is becoming an increasingly prominent dimension of medical device TIC